Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine.

NPJ Schizophrenia
Lennart KyllesøEspen Molden

Abstract

Adequate antipsychotic treatment intensity is required for defining treatment-resistant schizophrenia (TRS) and justifying clozapine treatment. We investigated the occurrence of undetectable or subtherapeutic serum levels of oral antipsychotics preceding switch to clozapine as an endpoint of TRS. For patients starting clozapine, 12-month retrospective reviews of antipsychotic serum concentration measurements were performed in a Norwegian therapeutic drug monitoring (TDM) database from 2005 to 2017. Undetectable levels in high-sensitive analytical assays defined 'no drug use', while levels <50% of the lower reference range defined 'subtherapeutic use'. Similar data were collected for patients switching to long-acting injectable (LAI) antipsychotics, as a reference of 'no or subtherapeutic drug use'. Nineteen of 353 patients initiating clozapine (5.4%) had a recent history of undetectable antipsychotic drug levels compared to 91 of 1048 (8.7%) initiating LAI. Another 19 patients starting clozapine (5.4%) had recent events of subtherapeutic levels. In conclusion, the present retrospective study may indicate that every 10th patient starting clozapine has a recent history of undetectable or subtherapeutic serum levels of oral antips...Continue Reading

References

Jan 2, 2004·The American Journal of Psychiatry·Dennis S Charney
Jul 29, 2004·Schizophrenia Bulletin·Marcia ValensteinThomas Stavenger
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Feb 23, 2008·Schizophrenia Research·Rajiv TandonHenry A Nasrallah
Oct 14, 2008·Psychiatry Research·Pierre-Michel Llorca
Jul 1, 2010·Expert Opinion on Pharmacotherapy·Ofer AgidGary Remington
Nov 27, 2010·Journal of Psychosomatic Research·Martha SajatovicGbenga Ogedegbe
Apr 11, 2012·British Journal of Clinical Pharmacology·Bernard VrijensUNKNOWN ABC Project Team
Jul 26, 2014·Patient Related Outcome Measures·Peter M HaddadJan Scott
Feb 18, 2016·CNS Drugs·Jimmi NielsenDavid Taylor
Oct 27, 2017·Acta Psychiatrica Scandinavica·R McCutcheonO D Howes
Mar 2, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Georgios SchoretsanitisChristoph Hiemke
Sep 1, 2018·Neurobiology of Disease·Frederick C NuciforaAkira Sawa
Nov 9, 2018·Expert Opinion on Pharmacotherapy·Justin Faden, Leslie Citrome
Sep 20, 2019·The Journal of Clinical Psychiatry·John M Kane, Christoph U Correll

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here